5lvm

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
m (Protected "5lvm" [edit=sysop:move=sysop])
Current revision (18:51, 18 October 2023) (edit) (undo)
 
(3 intermediate revisions not shown.)
Line 1: Line 1:
-
'''Unreleased structure'''
 
-
The entry 5lvm is ON HOLD
+
==Human PDK1 Kinase Domain in Complex with Adenine Bound to the ATP-Binding Site==
 +
<StructureSection load='5lvm' size='340' side='right'caption='[[5lvm]], [[Resolution|resolution]] 1.26&Aring;' scene=''>
 +
== Structural highlights ==
 +
<table><tr><td colspan='2'>[[5lvm]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5LVM OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5LVM FirstGlance]. <br>
 +
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.26&#8491;</td></tr>
 +
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=ADE:ADENINE'>ADE</scene>, <scene name='pdbligand=DTD:DITHIANE+DIOL'>DTD</scene>, <scene name='pdbligand=SEP:PHOSPHOSERINE'>SEP</scene></td></tr>
 +
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5lvm FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5lvm OCA], [https://pdbe.org/5lvm PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5lvm RCSB], [https://www.ebi.ac.uk/pdbsum/5lvm PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5lvm ProSAT]</span></td></tr>
 +
</table>
 +
== Function ==
 +
[https://www.uniprot.org/uniprot/PDPK1_HUMAN PDPK1_HUMAN] Serine/threonine kinase which acts as a master kinase, phosphorylating and activating a subgroup of the AGC family of protein kinases. Its targets include: protein kinase B (PKB/AKT1, PKB/AKT2, PKB/AKT3), p70 ribosomal protein S6 kinase (RPS6KB1), p90 ribosomal protein S6 kinase (RPS6KA1, RPS6KA2 and RPS6KA3), cyclic AMP-dependent protein kinase (PRKACA), protein kinase C (PRKCD and PRKCZ), serum and glucocorticoid-inducible kinase (SGK1, SGK2 and SGK3), p21-activated kinase-1 (PAK1), protein kinase PKN (PKN1 and PKN2). Plays a central role in the transduction of signals from insulin by providing the activating phosphorylation to PKB/AKT1, thus propagating the signal to downstream targets controlling cell proliferation and survival, as well as glucose and amino acid uptake and storage. Negatively regulates the TGF-beta-induced signaling by: modulating the association of SMAD3 and SMAD7 with TGF-beta receptor, phosphorylating SMAD2, SMAD3, SMAD4 and SMAD7, preventing the nuclear translocation of SMAD3 and SMAD4 and the translocation of SMAD7 from the nucleus to the cytoplasm in response to TGF-beta. Activates PPARG transcriptional activity and promotes adipocyte differentiation. Activates the NF-kappa-B pathway via phosphorylation of IKKB. The tyrosine phosphorylated form is crucial for the regulation of focal adhesions by angiotensin II. Controls proliferation, survival, and growth of developing pancreatic cells. Participates in the regulation of Ca(2+) entry and Ca(2+)-activated K(+) channels of mast cells. Essential for the motility of vascular endothelial cells (ECs) and is involved in the regulation of their chemotaxis. Plays a critical role in cardiac homeostasis by serving as a dual effector for cell survival and beta-adrenergic response. Plays an important role during thymocyte development by regulating the expression of key nutrient receptors on the surface of pre-T cells and mediating Notch-induced cell growth and proliferative responses. Provides negative feedback inhibition to toll-like receptor-mediated NF-kappa-B activation in macrophages. Isoform 3 is catalytically inactive.<ref>PMID:9094314</ref> <ref>PMID:9768361</ref> <ref>PMID:9707564</ref> <ref>PMID:9445476</ref> <ref>PMID:10480933</ref> <ref>PMID:10995762</ref> <ref>PMID:12167717</ref> <ref>PMID:14585963</ref> <ref>PMID:14604990</ref> <ref>PMID:10226025</ref> <ref>PMID:16207722</ref> <ref>PMID:16251192</ref> <ref>PMID:17327236</ref> <ref>PMID:17371830</ref> <ref>PMID:18835241</ref>
 +
<div style="background-color:#fffaf0;">
 +
== Publication Abstract from PubMed ==
 +
Allostery is a phenomenon observed in many proteins where binding of a macromolecular partner or a small-molecule ligand at one location leads to specific perturbations at a site not in direct contact with the region where the binding occurs. The list of proteins under allosteric regulation includes AGC protein kinases. AGC kinases have a conserved allosteric site, the phosphoinositide-dependent protein kinase 1 (PDK1)-interacting fragment (PIF) pocket, which regulates protein ATP-binding, activity, and interaction with substrates. In this study, we identify small molecules that bind to the ATP-binding site and affect the PIF pocket of AGC kinase family members, PDK1 and Aurora kinase. We describe the mechanistic details and show that although PDK1 and Aurora kinase inhibitors bind to the conserved ATP-binding site, they differentially modulate physiological interactions at the PIF-pocket site. Our work outlines a strategy for developing bidirectional small-molecule allosteric modulators of protein kinases and other signaling proteins.
-
Authors: Schulze, J.O., Saladino, G., Busschots, K., Neimanis, S., Suess, E., Odadzic, D., Zeuzem, S., Hindie, V., Herbrand, A.K., Lisa, M.N., Alzari, P.M., Gervasio, F.L., Biondi, R.M.
+
Bidirectional Allosteric Communication between the ATP-Binding Site and the Regulatory PIF Pocket in PDK1 Protein Kinase.,Schulze JO, Saladino G, Busschots K, Neimanis S, Suss E, Odadzic D, Zeuzem S, Hindie V, Herbrand AK, Lisa MN, Alzari PM, Gervasio FL, Biondi RM Cell Chem Biol. 2016 Sep 28. pii: S2451-9456(16)30302-6. doi:, 10.1016/j.chembiol.2016.06.017. PMID:27693059<ref>PMID:27693059</ref>
-
Description: Human PDK1 Kinase Domain in Complex with Adenine Bound to the ATP-Binding Site
+
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
-
[[Category: Unreleased Structures]]
+
</div>
-
[[Category: Neimanis, S]]
+
<div class="pdbe-citations 5lvm" style="background-color:#fffaf0;"></div>
-
[[Category: Hindie, V]]
+
 
-
[[Category: Odadzic, D]]
+
==See Also==
-
[[Category: Suess, E]]
+
*[[Pdk1 3D structures|Pdk1 3D structures]]
-
[[Category: Alzari, P.M]]
+
== References ==
-
[[Category: Biondi, R.M]]
+
<references/>
-
[[Category: Saladino, G]]
+
__TOC__
-
[[Category: Lisa, M.N]]
+
</StructureSection>
-
[[Category: Zeuzem, S]]
+
[[Category: Homo sapiens]]
-
[[Category: Herbrand, A.K]]
+
[[Category: Large Structures]]
-
[[Category: Schulze, J.O]]
+
[[Category: Alzari PM]]
-
[[Category: Busschots, K]]
+
[[Category: Biondi RM]]
-
[[Category: Gervasio, F.L]]
+
[[Category: Busschots K]]
 +
[[Category: Gervasio FL]]
 +
[[Category: Herbrand AK]]
 +
[[Category: Hindie V]]
 +
[[Category: Lisa MN]]
 +
[[Category: Neimanis S]]
 +
[[Category: Odadzic D]]
 +
[[Category: Saladino G]]
 +
[[Category: Schulze JO]]
 +
[[Category: Suess E]]
 +
[[Category: Zeuzem S]]

Current revision

Human PDK1 Kinase Domain in Complex with Adenine Bound to the ATP-Binding Site

PDB ID 5lvm

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools